Introduction: What is Eculizumab?
Eculizumab is a monoclonal antibody medication primarily used to treat certain rare and severe complement-mediated disorders. It works by inhibiting a specific part of the immune system, thereby preventing complement-mediated destruction of red blood cells and other target tissues. Eculizumab is marketed under the brand name Soliris and has gained recognition for its effectiveness in managing conditions like paroxysmal nocturnal hemoglobinuria (PNH) and atypical hemolytic uremic syndrome (aHUS).